MedTrace Logo

Clinical Evaluation of the OrthoPAT Advance System

NCT01756976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2013-11-20

Study results available
· View outcomes & findings →

Summary

This study is intended to provide additional performance data of the OrthoPAT Advance in routine orthopedic surgery.

Conditions

  • Transmission, Blood, Recipient/Donor

Interventions

DEVICE

OrthoPat Advance

The device will be used initially in hysterectomy procedures. After a confirmation of product quality, the device will be used in routine orthopedic procedures.

Sponsors & Collaborators

  • Haemonetics Corporation

    lead INDUSTRY

Principal Investigators

  • Jonathan Waters, MD · University of Pittsburgh Medial Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01756976 on ClinicalTrials.gov